

Handbook of Biological Therapeutic Proteins
Regulatory, Manufacturing, Testing, and Patent Issues
Samenvatting
Since 1972 when recombinant engineering was invented, over 500 therapeutic proteins have been approved. Today, biological drugs constitute almost 70% of all new drugs and are of biological origin. The first edition of this book dealt with biosimilars, the second focuses on new drugs yet limits to therapeutic proteins.